Kolon Life Science Inc (102940) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Kolon Life Science Inc (102940) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.58 Billion ≈ $1.75 Million USD) by net assets (₩346.41 Billion ≈ $234.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Kolon Life Science Inc worth for the company's overall valuation and market capitalisation.

Kolon Life Science Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Kolon Life Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kolon Life Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kolon Life Science Inc ranked by their cash flow conversion efficiency. Explore Kolon Life Science Inc (102940) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SynAct Pharma AB ST:SYNACT	-0.170x
Tesoro Gold Ltd AU:TSO	-0.013x
Excel Cell Electronic Co Ltd TW:2483	0.031x
Answear.com S.A. WAR:ANR	-0.093x
Coya Therapeutics, Inc. Common Stock NASDAQ:COYA	-0.316x
Seoyon Co Ltd KO:007860	0.053x
K N Kenanga Holdings Bhd KLSE:6483	-0.231x
GaeaSoft Corp KQ:051160	0.034x

Annual Cash Flow Conversion Efficiency for Kolon Life Science Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Kolon Life Science Inc from 2014 to 2024. View 102940 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩149.34 Billion ≈ $101.20 Million	₩-14.08 Billion ≈ $-9.55 Million	-0.094x	+47.78%
2023-12-31	₩137.67 Billion ≈ $93.30 Million	₩-24.87 Billion ≈ $-16.85 Million	-0.181x	-45.27%
2022-12-31	₩167.72 Billion ≈ $113.66 Million	₩-20.85 Billion ≈ $-14.13 Million	-0.124x	+23.64%
2021-12-31	₩99.41 Billion ≈ $67.37 Million	₩-16.19 Billion ≈ $-10.97 Million	-0.163x	-29.16%
2020-12-31	₩57.96 Billion ≈ $39.28 Million	₩-7.31 Billion ≈ $-4.95 Million	-0.126x	+36.89%
2019-12-31	₩101.02 Billion ≈ $68.46 Million	₩-20.18 Billion ≈ $-13.68 Million	-0.200x	-555.43%
2018-12-31	₩446.15 Billion ≈ $302.35 Million	₩-13.60 Billion ≈ $-9.22 Million	-0.030x	-100.45%
2017-12-31	₩545.41 Billion ≈ $369.62 Million	₩-8.29 Billion ≈ $-5.62 Million	-0.015x	-114.05%
2016-12-31	₩259.79 Billion ≈ $176.05 Million	₩28.11 Billion ≈ $19.05 Million	0.108x	-29.56%
2015-12-31	₩135.44 Billion ≈ $91.79 Million	₩20.81 Billion ≈ $14.10 Million	0.154x	+72.96%
2014-12-31	₩136.17 Billion ≈ $92.28 Million	₩12.10 Billion ≈ $8.20 Million	0.089x	--

About Kolon Life Science Inc

KQ:102940 Korea Pharmaceuticals

Market Cap

$109.55 Million

₩161.65 Billion KRW

Market Cap Rank

#18948 Global

#900 in Korea

Share Price

₩14170.00

Change (1 day)

+0.85%

52-Week Range

₩13300.00 - ₩70800.00

All Time High

₩163572.85